Personal information

No personal information available

Activities

Works (6)

PDE3A Is a Highly Expressed Therapy Target in Myxoid Liposarcoma

Cancers
2023-11-07 | Journal article
Contributors: Kirsi Toivanen; Sami Kilpinen; Kalle Ojala; Nanna Merikoski; Sami Salmikangas; Mika Sampo; Tom Böhling; Harri Sihto
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Transcriptomic analyses reveal three distinct molecular subgroups of Merkel cell carcinoma with differing prognoses

International Journal of Cancer
2023-05-15 | Journal article
Contributors: Benjamin Z. Sundqvist; Sami K. Kilpinen; Tom O. Böhling; Virve S. K. Koljonen; Harri J. Sihto
Source: check_circle
Crossref

Therapeutic opportunity of phosphodiesterase 3A modulators in myxoid liposarcomas

2022-12-09 | Preprint
Contributors: Kirsi Toivanen; Sami Kilpinen; Kalle Ojala; Astrid Murumägi; Mariliina Arjama; Nanna Merikoski; Sami Salmikangas; Olli Kallioniemi; Mika Sampo; Tom Böhling et al.
Source: check_circle
Crossref

Activation of Oncogenic and Immune-Response Pathways Is Linked to Disease-Specific Survival in Merkel Cell Carcinoma

Cancers
2022-07-23 | Journal article
Contributors: Benjamin Sundqvist; Sami Kilpinen; Tom Böhling; Virve Koljonen; Harri Sihto
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Tensin2 Is a Novel Diagnostic Marker in GIST, Associated with Gastric Location and Non-Metastatic Tumors

Cancers
2022-06-30 | Journal article
Contributors: Sami Salmikangas; Tom Böhling; Nanna Merikoski; Joanna Jagdeo; Mika Sampo; Tiina Vesterinen; Harri Sihto
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

LRIG1 is a positive prognostic marker in Merkel cell carcinoma and Merkel cell carcinoma expresses epithelial stem cell markers

Virchows Archiv
2021-12 | Journal article
Contributors: Benjamin Sundqvist; Harri Sihto; Maria von Willebrand; Tom Böhling; Virve Koljonen
Source: check_circle
Crossref